The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Artificial Intelligence in Diabetes Management-Global Market Insights and Sales Trends 2024

Artificial Intelligence in Diabetes Management-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1857351

No of Pages : 86

Synopsis

Artificial Intelligence in diabetes management is an automotion system which employs a computer system that gathers data, understands, reasons, and learns how the information effects outcomes over time.That the system ingests massive amounts of information—both structured and unstructured data—such as databases that have categorical variables, health records, and the scientific lexicon in research papers all of which is ingested and processed to make connections and then draw conclusions through a process of learning over time to increase in accuracy.

The global Artificial Intelligence in Diabetes Management market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Artificial Intelligence in Diabetes Management in various end use industries. The expanding demands from the Glucose Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices and Other Devices, are propelling Artificial Intelligence in Diabetes Management market. Case-based Reasoning, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intelligent Data Analysis segment is estimated at % CAGR for the next seven-year period.

As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.26%, including software, hardware and services.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artificial Intelligence in Diabetes Management, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Artificial Intelligence in Diabetes Management market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Artificial Intelligence in Diabetes Management market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artificial Intelligence in Diabetes Management sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Artificial Intelligence in Diabetes Management covered in this report include Apple, Diabnext, Glooko, Google, IBM, Tidepool and Vodafone, etc.

The global Artificial Intelligence in Diabetes Management market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Apple
  • Diabnext
  • Glooko
  • Google
  • IBM
  • Tidepool
  • Vodafone

Global Artificial Intelligence in Diabetes Management market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Artificial Intelligence in Diabetes Management market, Segment by Type:

  • Case-based Reasoning
  • Intelligent Data Analysis

Global Artificial Intelligence in Diabetes Management market, by Application

  • Glucose Monitoring Devices
  • Diagnostic Devices
  • Insulin Delivery Devices
  • Other Devices

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Artificial Intelligence in Diabetes Management companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Artificial Intelligence in Diabetes Management
1.1 Artificial Intelligence in Diabetes Management Market Overview
1.1.1 Artificial Intelligence in Diabetes Management Product Scope
1.1.2 Artificial Intelligence in Diabetes Management Market Status and Outlook
1.2 Global Artificial Intelligence in Diabetes Management Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Artificial Intelligence in Diabetes Management Market Size by Region (2018-2029)
1.4 Global Artificial Intelligence in Diabetes Management Historic Market Size by Region (2018-2023)
1.5 Global Artificial Intelligence in Diabetes Management Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Artificial Intelligence in Diabetes Management Market Size (2018-2029)
1.6.1 North America Artificial Intelligence in Diabetes Management Market Size (2018-2029)
1.6.2 Europe Artificial Intelligence in Diabetes Management Market Size (2018-2029)
1.6.3 Asia-Pacific Artificial Intelligence in Diabetes Management Market Size (2018-2029)
1.6.4 Latin America Artificial Intelligence in Diabetes Management Market Size (2018-2029)
1.6.5 Middle East & Africa Artificial Intelligence in Diabetes Management Market Size (2018-2029)
2 Artificial Intelligence in Diabetes Management Market by Type
2.1 Introduction
2.1.1 Case-based Reasoning
2.1.2 Intelligent Data Analysis
2.2 Global Artificial Intelligence in Diabetes Management Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Artificial Intelligence in Diabetes Management Historic Market Size by Type (2018-2023)
2.2.2 Global Artificial Intelligence in Diabetes Management Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Artificial Intelligence in Diabetes Management Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Artificial Intelligence in Diabetes Management Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Artificial Intelligence in Diabetes Management Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Artificial Intelligence in Diabetes Management Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Artificial Intelligence in Diabetes Management Revenue Breakdown by Type (2018-2029)
3 Artificial Intelligence in Diabetes Management Market Overview by Application
3.1 Introduction
3.1.1 Glucose Monitoring Devices
3.1.2 Diagnostic Devices
3.1.3 Insulin Delivery Devices
3.1.4 Other Devices
3.2 Global Artificial Intelligence in Diabetes Management Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Artificial Intelligence in Diabetes Management Historic Market Size by Application (2018-2023)
3.2.2 Global Artificial Intelligence in Diabetes Management Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Artificial Intelligence in Diabetes Management Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Artificial Intelligence in Diabetes Management Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Artificial Intelligence in Diabetes Management Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Artificial Intelligence in Diabetes Management Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Artificial Intelligence in Diabetes Management Revenue Breakdown by Application (2018-2029)
4 Artificial Intelligence in Diabetes Management Competition Analysis by Players
4.1 Global Artificial Intelligence in Diabetes Management Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Artificial Intelligence in Diabetes Management as of 2022)
4.3 Date of Key Players Enter into Artificial Intelligence in Diabetes Management Market
4.4 Global Top Players Artificial Intelligence in Diabetes Management Headquarters and Area Served
4.5 Key Players Artificial Intelligence in Diabetes Management Product Solution and Service
4.6 Competitive Status
4.6.1 Artificial Intelligence in Diabetes Management Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Apple
5.1.1 Apple Profile
5.1.2 Apple Main Business
5.1.3 Apple Artificial Intelligence in Diabetes Management Products, Services and Solutions
5.1.4 Apple Artificial Intelligence in Diabetes Management Revenue (US$ Million) & (2018-2023)
5.1.5 Apple Recent Developments
5.2 Diabnext
5.2.1 Diabnext Profile
5.2.2 Diabnext Main Business
5.2.3 Diabnext Artificial Intelligence in Diabetes Management Products, Services and Solutions
5.2.4 Diabnext Artificial Intelligence in Diabetes Management Revenue (US$ Million) & (2018-2023)
5.2.5 Diabnext Recent Developments
5.3 Glooko
5.3.1 Glooko Profile
5.3.2 Glooko Main Business
5.3.3 Glooko Artificial Intelligence in Diabetes Management Products, Services and Solutions
5.3.4 Glooko Artificial Intelligence in Diabetes Management Revenue (US$ Million) & (2018-2023)
5.3.5 Google Recent Developments
5.4 Google
5.4.1 Google Profile
5.4.2 Google Main Business
5.4.3 Google Artificial Intelligence in Diabetes Management Products, Services and Solutions
5.4.4 Google Artificial Intelligence in Diabetes Management Revenue (US$ Million) & (2018-2023)
5.4.5 Google Recent Developments
5.5 IBM
5.5.1 IBM Profile
5.5.2 IBM Main Business
5.5.3 IBM Artificial Intelligence in Diabetes Management Products, Services and Solutions
5.5.4 IBM Artificial Intelligence in Diabetes Management Revenue (US$ Million) & (2018-2023)
5.5.5 IBM Recent Developments
5.6 Tidepool
5.6.1 Tidepool Profile
5.6.2 Tidepool Main Business
5.6.3 Tidepool Artificial Intelligence in Diabetes Management Products, Services and Solutions
5.6.4 Tidepool Artificial Intelligence in Diabetes Management Revenue (US$ Million) & (2018-2023)
5.6.5 Tidepool Recent Developments
5.7 Vodafone
5.7.1 Vodafone Profile
5.7.2 Vodafone Main Business
5.7.3 Vodafone Artificial Intelligence in Diabetes Management Products, Services and Solutions
5.7.4 Vodafone Artificial Intelligence in Diabetes Management Revenue (US$ Million) & (2018-2023)
5.7.5 Vodafone Recent Developments
6 North America
6.1 North America Artificial Intelligence in Diabetes Management Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Artificial Intelligence in Diabetes Management Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence in Diabetes Management Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Artificial Intelligence in Diabetes Management Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence in Diabetes Management Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Artificial Intelligence in Diabetes Management Market Dynamics
11.1 Artificial Intelligence in Diabetes Management Industry Trends
11.2 Artificial Intelligence in Diabetes Management Market Drivers
11.3 Artificial Intelligence in Diabetes Management Market Challenges
11.4 Artificial Intelligence in Diabetes Management Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’